Immunic Inc’s filing revealed that its Director Rudick Richard Alan acquired Company’s shares for reported $0.1 million on Nov 12 ’24. In the deal valued at $1.15 per share,87,300 shares were bought. As a result of this transaction, Rudick Richard Alan now holds 87,300 shares worth roughly $86427.0.
William Blair initiated its Immunic Inc [IMUX] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late November with a ‘”a Buy”‘ rating. B. Riley Securities started covering the stock on August 27, 2024. It rated IMUX as “a Buy”.
Price Performance Review of IMUX
On Monday, Immunic Inc [NASDAQ:IMUX] saw its stock fall -2.31% to $0.99. Over the last five days, the stock has lost -11.90%. Immunic Inc shares have fallen nearly -1.33% since the year began. Nevertheless, the stocks have fallen -22.31% over the past one year. While a 52-week high of $2.11 was reached on 02/21/25, a 52-week low of $0.83 was recorded on 04/09/25. SMA at 50 days reached $1.0824, while 200 days put it at $1.2203.
Levels Of Support And Resistance For IMUX Stock
The 24-hour chart illustrates a support level at 0.9545, which if violated will result in even more drops to 0.9222. On the upside, there is a resistance level at 1.0345. A further resistance level may holdings at 1.0822. The Relative Strength Index (RSI) on the 14-day chart is 45.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0839, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.81%. Stochastics %K at 15.44% indicates the stock is a buying.
